Alexander is Head of Product Line Management & Product Innovation. He owns a wide range of experience and knowledge in various and different industries such as jewellery, manufacturing industry and biopharma, and multiple areas of activities due to his highly technical education and intensive insights.
Passionate for Automation, Engineering and Process Management Alexander contributes to the innovative focus of advancing cold chain management within the biopharmaceutical industry.
Vaccines
Freezing and thawing are essential steps in the cold chain management of biosimilars. With several methods eligible, we have chosen some prominent ones, explaining their advantages, limitations, and our preferred choices.
Alexander Fuchs
May 8, 2024
Vaccines
Once biologics are produced, they need to be stored for shorter or longer periods of time, with dedicated storage requirements to be met. Here, we will uncover these requirements, along with solutions to fulfill them.
Alexander Fuchs
May 8, 2024
Vaccines
There is more than one way to prepare biologics for long-term storage under temperature-controlled conditions – in this article, we will explore some of the main freezing methods.
Alexander Fuchs
May 6, 2024
Vaccines
Therapeutic proteins hold promise in the treatment of numerous medical conditions, and progress in this field is far from being over. This is reason enough to take a general look at this class of therapeutics.
Alexander Fuchs
April 10, 2024
Vaccines
Prior to be used in diagnostics or therapeutics, proteins have to be safely stored. In this article, we will assess methods to preserve their stability upon storage.
Alexander Fuchs
April 10, 2024
Vaccines
Active pharmaceutical ingredients (APIs) are fundamental for drug products to be effective, but require special treatment – e.g. considering humidity, light, or temperature. In this article, we will highlight the different cold storage requirements of APIs, including examples and an overview of different practical approaches.
Alexander Fuchs
March 21, 2024
Cell & Gene Therapy
In a recent study, freezing protocols were tested with the RoSS.LN2F controlled liquid nitrogen freezer to find the optimal freezing rate for CHO-K1 cells in order to achieve maximum cell viability.
Alexander Fuchs
February 16, 2024
Monoclonal Antibodies
mAb production requires high levels of expertise and precision, as well as specialized equipment. Nonetheless, there are several challenges that manufacturers have to deal with.
Alexander Fuchs
February 6, 2024
Monoclonal Antibodies
In many cases, antibodies need to be stored for varying time spans before further processing or administration. Hence, it is essential to mind the characteristic storage requirements of these valuable biologics.
Alexander Fuchs
February 5, 2024
Monoclonal Antibodies
Scale-up has to be considered already in early stages of monoclonal antibody production. But what do manufacturers have to bear in mind? We'll find out in this article.
Alexander Fuchs
January 18, 2024
Vaccines
Vaccine manufacturing with its fascinating process – from development to large-scale production. Learn more about Vaccine Development ✓ Vaccine Production ✓ Manufacturing processes ✓ Companies ✓ Platforms ✓ Benefits & challenges ✓ cGMP ✓ Solutions
Alexander Fuchs
September 26, 2024
Freeze & Thaw
Freezing small volumes extends beyond laboratory settings to include commercialized manufacturing processes for small batches in biomanufacturing, like cell banking, gene therapies utilizing viral vectors, lipid nanoparticles, and fill & finish procedures.
Alexander Fuchs
November 20, 2023
